(Q79849197)

English

Bioactive constituents from Chinese natural medicines. XXII. Absolute structures of new megastigmane glycosides, sedumosides E1, E2, E3, F1, F2, and G, from Sedum sarmentosum (Crassulaceae)

scientific article published on 01 March 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329886%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Bioactive constituents from Chinese natural medicines. XXII. Absolute structures of new megastigmane glycosides, sedumosides E1, E2, E3, F1, F2, and G, from Sedum sarmentosum (Crassulaceae) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329886%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Sedum sarmentosum

1 reference

Isorhamnetin 3-glucoside-7-rhamnoside

1 reference

3-[(2-O-beta-D-Glucopyranosyl-alpha-L-rhamnopyranosyl)oxy]-7-[(alpha-L-rhamnopyranosyl)oxy]-3',4',5-trihydroxyflavone

1 reference

(+)-Isolariciresinol 9'-O-glucoside

1 reference

3,7-Bis(beta-D-glucopyranosyloxy)-4',5-dihydroxy-8-methoxyflavone

1 reference

(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-{4-[(2S,3R,4R)-3-(hydroxymethyl)-4-[(3-methoxy-4-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl]oxolan-2-yl]-2-methoxyphenoxy}oxane-3,4,5-triol

1 reference

1 reference

1 reference

7-[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-methyl-3-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)-3-[(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one

1 reference

Isolariciresinol 4-O-|A-D-glucopyranoside

1 reference

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(E,2R)-4-[(1R,4S,6R)-4-hydroxy-2,2,6-trimethylcyclohexyl]but-3-en-2-yl]oxyoxane-3,4,5-triol

1 reference

(2R)-2,3-Dihydro-2beta-(3-methoxy-4-hydroxyphenyl)-3alpha-[(beta-D-glucopyranosyloxy)methyl]-7-methoxybenzofuran-5-(1-propanol)

1 reference

1 reference

(3S,5R,6S,9R)-Megastigmane-3,9-diol

1 reference

3-(2-O-beta-D-Glucopyranosyl-alpha-L-rhamnopyranosyloxy)-4',5-dihydroxy-7-(alpha-L-rhamnopyranosyloxy)flavone

1 reference

5,7-Dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-methoxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one

1 reference

Rha(a1-2)Glc(b)-O-EtPh

1 reference

(4S)-8-(beta-D-Glucopyranosyloxy)-p-mentha-1-ene-7-ol

1 reference

(2S,3R,4S,5S,6R)-2-[4-[[(3R,4R,5S)-5-(4-hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)oxolan-3-yl]methyl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

1 reference

3,5-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-7-[(2S,3S,4S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one

1 reference

kaempferol 7-O-glucoside

1 reference

Myrsinionoside D

1 reference

isorhamnetin 7-O-beta-D-glucopyranoside

1 reference

Quercetin 3,7-glycoside

1 reference

Kaempferol-7-o-glucoside

1 reference

1 reference

7-{[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-5-hydroxy-2-(4-hydroxyphenyl)-3-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}chromen-4-one

1 reference

1-Acetyl-beta-carboline

1 reference

(+)-isolariciresinol

1 reference

(2R,3S,4S,5R,6R)-2-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-[(2R)-4-[(1S,4S,6R)-4-hydroxy-2,2,6-trimethylcyclohexyl]butan-2-yl]oxyoxane-3,4,5-triol

1 reference

quercetin 3,7-di-O-alpha-L-rhamnoside

1 reference

5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one

1 reference

Myrsinionoside A

1 reference

1 reference

tricin 7-O-beta-D-glucoside

1 reference

5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-methoxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one

1 reference

2-(4-Hydroxy-3-methoxyphenyl)-3,5-dihydroxy-7-[3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy]-4H-1-benzopyran-4-one

1 reference

Isorhamnetin-3,7-diglucoside

1 reference

1 reference

5-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-7-[(2S,3R,4S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one

1 reference

phenylethyl beta-D-glucopyranoside

1 reference

2-[(4S)-1-(beta-D-Glucopyranosyloxymethyl)-1-cyclohexene-4-yl]-2-propanol

1 reference

[(4S)-p-Mentha-1-ene-8-yl]beta-D-glucopyranoside

1 reference

(2S,3R,4S,5S,6R)-2-[[(6R,7S,8S)-8-(4-hydroxy-3-methoxyphenyl)-6,7-bis(hydroxymethyl)-3-methoxy-5,6,7,8-tetrahydronaphthalen-2-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

1 reference

eugenyl glucoside

1 reference

(2S,3R,4S,5R,6R)-2-[4-[(3R,3aS,6R,6aS)-6-[3-methoxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

1 reference

Cyclo(D-Leu-L-Pro)

1 reference

3-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-7-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one

1 reference

isorhamnetin-3,7-diglucoside

1 reference

1 reference

(2S,3R,4R,5R,6R)-2-methyl-6-[[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[(E,2R)-4-[(1R,4S,6R)-4-hydroxy-2,2,6-trimethylcyclohexyl]but-3-en-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol

1 reference

Sarmentoic acid

1 reference

Cyclolariciresinol

1 reference

Oct-1-en-3-yl Ara (1-6)Glu

1 reference

(6R,7S,8S)-8-(4-hydroxy-3-methoxyphenyl)-6,7-bis(hydroxymethyl)-3-methoxy-5,6,7,8-tetrahydronaphthalen-2-ol

1 reference

3,7-Bis(beta-D-glucopyranosyloxy)-4',5-dihydroxy-3',8-dimethoxyflavone

1 reference

(2S,3R,4R,5R,6R)-2-methyl-6-[[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[(2R)-4-[(1S,4S,6R)-4-hydroxy-2,2,6-trimethylcyclohexyl]butan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol

1 reference

[(1R)-3aalpha,4,6,6aalpha-Tetrahydro-1H,3H-furo[3,4-c]furan-1alpha,4alpha-diyl]bis(2-methoxy-4,1-phenylene)bis(beta-D-glucopyranoside)

1 reference

(2S,3R,4R,5R,6R)-2-methyl-6-[[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[(1S,4S,5R)-4-[(3R)-3-hydroxybutyl]-3,3,5-trimethylcyclohexyl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol

1 reference

Cyclo(isoleucyl-prolyl)

1 reference

1 reference

secoisolariciresinol

1 reference

1 reference

based on heuristic

inferred from title

1 reference

5-hydroxy-2-(4-hydroxyphenyl)-8-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one

1 reference

BPCSUHDJRATFGO-UJBZIIBZSA-N

1 reference

4-(4-hydroxy-2,2,6-trimethylcyclohexyl)butan-2-one

1 reference

3-[(2S,3S,4R,5R,6R)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5-hydroxy-7-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one

1 reference

5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-methoxy-7-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one

1 reference

4-(3-Hydroxybut-1-en-1-yl)-3,3,5-trimethylcyclohexan-1-ol

1 reference

Isorhamnetin 3-O-beta-glucopyranoside-7-O-alpha-rhamnopyranoside

1 reference

Cyclo(leucylprolyl)

1 reference

1 reference

(2R,3R,4S,5S,6S)-2-[[(2S,3R)-2-(4-hydroxy-3-methoxyphenyl)-5-(3-hydroxypropyl)-7-methoxy-2,3-dihydro-1-benzofuran-3-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

1 reference

Petrosedum pruinatum

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

Toshio Morikawa

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329886%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Yi Zhang

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329886%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Seikou Nakamura

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329886%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Hisashi Matsuda

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329886%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Osamu Muraoka

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329886%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Masayuki Yoshikawa

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329886%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

1 reference

Chemical & Pharmaceutical Bulletin

publication date

2007

1 reference

16 September 2022

full work available at URL

https://www.jstage.jst.go.jp/article/cpb/55/3/55_3_435/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.55.435?email=unpaywall_01@example.com

Chemical & Pharmaceutical Bulletin

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329886%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

55

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329886%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329886%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

435-441

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329886%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

online access status

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.55.435?email=unpaywall_01@example.com

access restriction status

1 reference

based on heuristic

inferred from online access status

[Constituents of the leaves of Daphne pseudo-mezereum]

2 references

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/YAKUSHI1947.113.9_670

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

Bioactive constituents from Chinese natural medicines. XVII. constituents with radical scavenging effect and new glucosyloxybenzyl 2-isobutylmalates from Gymnadenia conopsea

2 references

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.54.506

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

Medicinal flowers. VI. Absolute stereostructures of two new flavanone glycosides and a phenylbutanoid glycoside from the flowers of Chrysanthemum indicum L.: their inhibitory activities for rat lens aldose reductase

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.50.972

New Lignan Glucosides from Stemmadenia minima*

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

Medicinal foodstuffs. XXXI. Structures of new aromatic constituents and inhibitors of degranulation in RBL-2H3 cells from a Japanese folk medicine, the stem bark of Acer nikoense.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.51.62

Water-soluble constituents of cumin: monoterpenoid glucosides

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

Hepatoprotective principles from the flowers of Tilia argentea (linden): structure requirements of tiliroside and mechanisms of action

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

Glucosyloxybenzyl 2-Isobutylmalates from the tubers of Gymnadenia conopsea

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

13C NMR spectral analysis of lignans from Araucaria angustifolia

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

Abscisic acid related compounds and lignans in prunes (Prunus domestica L.) and their oxygen radical absorbance capacity (ORAC).

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

Megastigmanes and their glucosides from the whole plant of Sedum sarmentosum

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

Medicinal flowers. I. Aldose reductase inhibitors and three new eudesmane-type sesquiterpenes, kikkanols A, B, and C, from the flowers of Chrysanthemum indicum L

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.47.340

Structures of new beta-carboline-type alkaloids with antiallergic effects from Stellaria dichotoma(1,2)

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

Absolute stereostructures of new arborinane-type triterpenoids and inhibitors of nitric oxide production from Rubia yunnanensis

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

beta-Carboline alkaloids from hypodematium squamuloso-pilosum

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

The flavonoids of the Fagonia arabica-complex (zygophyllaceae)

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

Bioactive constituents from Chinese natural medicines. XIV. New glycosides of beta-carboline-type alkaloid, neolignan, and phenylpropanoid from Stellaria dichotoma L. var. lanceolata and their antiallergic activities.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.52.1194

Structural investigations of flavonol glycosides from sea buckthorn (Hippophaë rhamnoides) pomace by NMR spectroscopy and HPLC-ESI-MS(n).

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

Inhibitors of nitric oxide production from the bark of Myrica rubra: structures of new biphenyl type diarylheptanoid glycosides and taraxerane type triterpene

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

Phenylethanoid oligoglycosides and acylated oligosugars with vasorelaxant activity from Cistanche tubulosa

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

Bioactive constituents from Chinese natural medicines. XX. Inhibitors of antigen-induced degranulation in RBL-2H3 cells from the seeds of Psoralea corylifolia.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.55.106

Myrsinionosides A-E: megastigmane glycosides from the leaves of Myrsine seguinii Lev

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.49.1093

Bioactive constituents of Chinese natural medicines. VII. Inhibitors of degranulation in RBL-2H3 cells and absolute stereostructures of three new diarylheptanoid glycosides from the bark of Myrica rubra

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.50.208

Studies on the constituents of leaves of Citrus unshiu MARCOV.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.36.5004

Monoterpene constituents from Cistanche tubulosa--chemical structures of kankanosides A-E and kankanol-

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.54.669

Studies on the constituents of Clematis species. VI. The constituents of Clematis stans Sieb. et Zucc

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.43.2187

Bioactive constituents from Chinese natural medicines. XV. Inhibitory effect on aldose reductase and structures of Saussureosides A and B from Saussurea medusa

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.53.1416

Bioactive constituents from Chinese natural medicines. XI. inhibitors on NO production and degranulation in RBL-2H3 from Rubia yunnanensis: structures of rubianosides II, III, and IV, rubianol-g, and rubianthraquinone

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.51.654

Antiallergic phenanthrenes and stilbenes from the tubers of Gymnadenia conopsea

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

Flavonoids of Ochradenus baccatus

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

In vitro algal growth inhibition by phytotoxins ofTypha latifolia L.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

New and known diketopiperazines from the Caribbean sponge, Calyx cf. podatypa.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

Perilloside a, a monoterpene glucoside from Perilla frutescens

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

Absolute stereostructures of three new sesquiterpenes from the fruit of Alpinia oxyphylla with inhibitory effects on nitric oxide production and degranulation in RBL-2H3 cells.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

Structures of new cyclic diarylheptanoids and inhibitors of nitric oxide production from Japanese folk medicine Acer nikoense

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

Bioactive Isoflavonols and Other Components fromTrifolium subterraneum

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.55.435

Identifiers

10.1248/CPB.55.435

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329886%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329886%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79849197&oldid=2132864789"